Patents by Inventor Geoffrey L. Hammond

Geoffrey L. Hammond has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Variants of human corticosteroid binding globulin
    Patent number: 5595969
    Abstract: A novel steroid-binding variant of human corticosteroid binding globulin in which one or more of the glycosylation sites, other than the glycosylation site at amino acid position 238, has been functionally disrupted is complexed with an anti-inflammatory ligand in the treatment of inflammation in mammals.
    Type: Grant
    Filed: April 14, 1995
    Date of Patent: January 21, 1997
    Assignee: Allelix Biopharmaceutical Inc.
    Inventors: Geoffrey L. Hammond, George V. Avvakumov
  • DNA encoding variants of human corticosteroid binding globulin
    Patent number: 5432080
    Abstract: A novel steroid-binding variant of human corticosteroid binding globulin in which one or more of the glycosylation sites, other than the glycosylation site at amino acid position 238, has been functionally disrupted is complexed with an anti-inflammatory ligand in the treatment of inflammation in mammals.
    Type: Grant
    Filed: December 16, 1992
    Date of Patent: July 11, 1995
    Assignee: Allelix Biopharmaceuticals Inc.
    Inventors: Geoffrey L. Hammond, George V. Avvakumov
  • Pharmaceutical compositions for use in treating inflammation
    Patent number: 5344819
    Abstract: Inflammation in mammals is treated by administering anti-inflammatory agent complexed with corticosteroid binding globulin (CBG) that is produced by recombinant DNA-based techniques.
    Type: Grant
    Filed: February 3, 1992
    Date of Patent: September 6, 1994
    Assignee: Allelix Biopharmaceuticals Inc.
    Inventor: Geoffrey L. Hammond
  • Pharmaceutical compositions and use thereof in treating inflammation
    Patent number: 5086039
    Abstract: Inflammation in mammals is treated by administering anti-inflammatory agent complexed with corticosteroid binding globulin (CBG).
    Type: Grant
    Filed: March 4, 1991
    Date of Patent: February 4, 1992
    Assignee: Allelix Biopharmaceuticals, Inc.
    Inventor: Geoffrey L. Hammond
  • Pharmaceutical compositions and use thereof in treating inflammation
    Patent number: 4997814
    Abstract: Inflammation in mammals is treated by administering anti-inflammatory agent complexed with corticosteroid binding globulin (CBG).
    Type: Grant
    Filed: June 9, 1988
    Date of Patent: March 5, 1991
    Assignee: Allelix Biopharmaceuticals, Inc.
    Inventor: Geoffrey L. Hammond